RE:Covid SpikeWell will make increasing revenue no matter what happens. This next quarter ttm looses a 17 million and gains a +100 million. Problem is that none of that is a surprise. Investors know the run rate is 500 million by end of 2022. An IPO on Nasdaq won't help SP either. Well needs surprise earnings. Risk is out of favor this year period. With rates inevitably rising, WELL has a lot of debt that will cost more to service. Last quarter alone intrest expense went from 1.2 to 2.6 million a huge increase.That doesn't include debentures intrest,which is 3.85 million a year. That payment is not till next December but investors are already calculating that in. Normal accepted P/S in about 3. Depending on future growth expectations maybe 6 is tops. That's normal not the insane garbage seen the last few years. The stock price will not rise if Well doesn't beat estimates by better than 20+%. If they do all that growth will be organic, which will be rewarded. By Well being in both clinics and SaaS they protect their revenue well, but when one is up the other is down. Investors see Well as a contradiction. We all know the biggest chunk of revenue comes from in person, but virtual is growing fastest. Most All the organic growth will come from virtual. IMO well needs to break up the company into in person and virtual. Hamed then issues the same amount of shares as Well has now for release in the ipo.That should be the NASDAQ listing, the virtual side IPO then all the proceeds minus expenses given out in special dividend to existing shareholders. Well still controls and operates it all, just now there are 2 different companies to invest in. Obviously Well stock price falls but we have the dividend to use if we want to buy the virtual side. IMO investors don't like the fact that it's virtual and in person are mixed together. Just my opinion.